Thermo Fisher Scientific’s clinical research business wins CRO awards in Asia-Pacific
WILMINGTON, N.C. (April 1, 2024) – The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been named a winner at the 2024 Asia-Pacific Biopharma Excellence Awards ceremony held in Singapore, receiving two Best Clinical Trials Supplier Awards in the categories of Site Innovation and Supply Chain Management.
“We are committed to meeting the needs of our customers as they develop life-changing therapeutics and vaccines for people around the world, including in Asia-Pacific,” said Alice Donnelly, senior vice president, head of project delivery, clinical research, Thermo Fisher Scientific. “We are strategically positioned within the Asia-Pacific region to execute effective development programs and provide end-to-end services to accelerate our customers’ vital research initiatives.”
With more than 25 years of local experience and approximately 6,000 in-region staff in Asia-Pacific, the business provides comprehensive clinical research organization (CRO) services and operational expertise to ensure quality delivery for customers. The business’ range of services in the region includes biostatistics, central laboratories, medical communications and one of the most experienced regulatory teams in the region.
Earlier this year, PPD-SNBL, a joint venture with Shin Nippon Biomedical Laboratories Ltd., was named a “Top CRO” in Asia-Pacific by Pharma Tech Outlook. PPD-SNBL provides a wide array of high-quality services ranging from monitoring all stages of clinical development to regulatory consulting for clinical trials in Japan.
“Our goal is to maintain the highest standards of quality in our services by leveraging our resources, expertise and capabilities to continue to strengthen our footprint in Japan,” said Yasumasa Kurioka, PPD-SNBL vice president and general manager, clinical research, Thermo Fisher Scientific. “The award reinforces PPD-SNBL’s proven track record of high-quality delivery and trust within Japan’s CRO marketplace.”
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Media Contact Information:
Nadine Maeser
(910) 558-4779